Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications
July 30 2020 - 07:00AM
Business Wire
JPK NanoRacer® Follows Molecular Dynamics in
Real Time at 50 Frames per Second
Bruker Corporation (Nasdaq: BRKR) today announced the release of
the NanoRacer high-speed AFM system. With an unprecedented imaging
speed of 50 frames per second, this sets a new milestone in
high-speed scanning capabilities to enable true real-time
visualization of dynamic biological processes using atomic force
microscopy (AFM). Developed in close collaboration with leading
experts in the field, the NanoRacer also delivers atomic
resolution and unmatched user friendliness, and it is expected to
provide crucial insights into single-molecule behavior and an
in-depth understanding of dynamic processes in biochemistry,
molecular biology, and biomedicine.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200730005016/en/
NanoRacer High-Speed AFM (Photo: Business
Wire)
“So many things are still hidden in biological molecules,”
stated Toshio Ando, Professor at the Nano Life Science Institute
(WPI-NanoLSI) of Kanazawa University in Japan. “To uncover their
unexplored secrets, there is a true need to directly observe
individual molecules during their functional activity. As the
fastest commercial, high-speed AFM available, the NanoRacer
enables this direct observation in real-time. A lot of innovative
ideas have been incorporated for easy operation and high
performance, and it is my utmost wish that many researchers will
use the NanoRacer to make exciting discoveries.”
“The NanoRacer system is the satisfying culmination of a
series of Bruker innovations in high-speed AFM,” added Torsten
Jähnke, Bruker’s Director of BioAFM. “From both a performance and
usability standpoint, we believe the NanoRacer will
revolutionize high-end atomic force microscopy for single-molecule
applications. Researchers from biochemistry, molecular biology, and
molecular medicine now have, for the first time, an AFM tool that
enables them to watch molecules at work and understand
structure-function relationships in depth.”
About the JPK NanoRacer High-Speed AFM The NanoRacer
system is designed for use with small cantilevers. It can achieve
top speeds of 50 frames/sec in fluid, in a 100nm x 100nm scan
range, and with 10k pixels. Equipped with photothermal cantilever
excitation, a new XYZ flexure scanner architecture, and lowest
noise positioning sensors in each axis, the NanoRacer sets a
new benchmark for high-end research AFM capabilities. Lowest forces
and highest resolution, combined with utmost stability, make it a
powerhouse for advanced applications and discoveries on the
molecular scale. The new system also incorporates JPK’s
high-performance Vortis™ 2 controller and intuitive software user
interface for superior ease-of-use operation. The fully automated
setup capabilities allow researchers to focus on their experiments,
making the NanoRacer system perfect for multi-user
environments or imaging facilities.
About the JPK BioAFM Business JPK joined Bruker in July 2018,
bringing in-depth expertise in live-cell imaging, cellular
mechanics, adhesion, and molecular force measurements, optical
trapping, and biological stimulus-response characterization to
Bruker’s worldwide infrastructure and established instrumentation
development and support. The JPK BioAFM business takes full
advantage of the best of both histories to provide microscopy
instrumentation for biomolecular and cellular imaging, as well as
force measurements on single molecules, cells and tissues. To learn
more about Bruker’s biological research AFMs, please visit:
www.bruker.com/BioAFM.
About Bruker Corporation (Nasdaq: BRKR) Bruker is enabling
scientists to make breakthrough discoveries and develop new
applications that improve the quality of human life. Bruker’s
high-performance scientific instruments and high-value analytical
and diagnostic solutions enable scientists to explore life and
materials at molecular, cellular and microscopic levels. In close
cooperation with our customers, Bruker is enabling innovation,
improved productivity and customer success in life science
molecular research, in applied and pharma applications, in
microscopy and nanoanalysis, and in industrial applications, as
well as in cell biology, preclinical imaging, clinical phenomics
and proteomics research and clinical microbiology. For more
information, please visit: www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200730005016/en/
Investor Contact: Miroslava Minkova Director, Investor
Relations & Corporate Development Bruker Corporation T: +1
(978) 663-3660 x1479 E: Investor.Relations@bruker.com
Media Contact: Dr. Gabriela Bagordo Communications
Manager BioAFM Bruker Nano GmbH T: +49 (30) 726243 500 E:
Gabriela.Bagordo@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Feb 2024 to Mar 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Mar 2023 to Mar 2024